Regorafenib antagonizes BCRP-mediated multidrug resistance in colon cancer.
Zhang YK, Wang YJ, Lei ZN, Zhang GN, Zhang XY, Wang DS, Al-Rihani SB, Shukla S, Ambudkar SV, Kaddoumi A, Shi Z, Chen ZS.
Zhang YK, et al. Among authors: wang ds, wang yj.
Cancer Lett. 2019 Feb 1;442:104-112. doi: 10.1016/j.canlet.2018.10.032. Epub 2018 Oct 28.
Cancer Lett. 2019.
PMID: 30392788
Free PMC article.